S. M. Luger Et Al. , "Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS," BONE MARROW TRANSPLANTATION , vol.47, no.2, pp.203-211, 2012
Luger, S. M. Et Al. 2012. Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. BONE MARROW TRANSPLANTATION , vol.47, no.2 , 203-211.
Luger, S. M., Ringden, O., Zhang, M., Perez, W. S., Bishop, M. R., Bornhauser, M., ... Bredeson, C. N.(2012). Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. BONE MARROW TRANSPLANTATION , vol.47, no.2, 203-211.
Luger, S. Et Al. "Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS," BONE MARROW TRANSPLANTATION , vol.47, no.2, 203-211, 2012
Luger, S. M. Et Al. "Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS." BONE MARROW TRANSPLANTATION , vol.47, no.2, pp.203-211, 2012
Luger, S. M. Et Al. (2012) . "Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS." BONE MARROW TRANSPLANTATION , vol.47, no.2, pp.203-211.
@article{article, author={S. M. Luger Et Al. }, title={Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS}, journal={BONE MARROW TRANSPLANTATION}, year=2012, pages={203-211} }